Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-11

Clinical Trial Update: Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis [Phase 1]

View source ↗

Summary

Phase 1 pilot study of intralymphatic immunotherapy (ILIT) for allergic rhinitis triggered by house dust mite, cat, and dog allergens has completed. The documen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intralymphatic immunotherapy (ILIT) (Intralymphatic immunotherapy)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED